Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
C
CV
vs
S&P 500
S&P 500
Over the past 12 months, CV has significantly outperformed S&P 500, delivering a return of +42% compared to S&P 500's +17% growth.
Stocks Performance
CV vs S&P 500
Performance Gap
CV vs S&P 500
Performance By Year
CV vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
CapsoVision Inc
Glance View
CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California and currently employs 28 full-time employees. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.